U.S. News & World Report Ranks HP&M as Top Tier FDA Law Firm - 2nd Year in a Row!

Recent FDA Law Blog Entries from www.fdalawblog.net

Drug Shortage Prevention Act Seeks to Improve Communication and Expedite Review of Drugs in Shortage

A Solution in Search of a Problem: Safety of Untested and New Devices Act of 2012

GAO Report Criticizes FDA on Antibiotic Labeling; Finds No Evidence of Encouraged Innovation

PTO Challenged After Denying a Patent Term Extension Based on First Commercial Marketing or Use Grounds

Articles and Presentations

Proper Reform Is Needed of the Appeals Process at the US Food and Drug Administration's Device Center  January 2012

CMS Proposed Rule on Reporting of Payments or Transfers of Value and Physician Ownership or Investment Interests  December 22, 2011

Court Ruling Casts Doubt On FDA's Use Of Guidance Documents  December 16, 2011

HP&M Files Comments on Draft NDI Guidance; Request Withdrawal and Reissuance Reflecting DSHEA Intent  December 2011

Death, Taxes and DEA Inspections: Dealing with the Inevitable  November/December 2011

more articles...